BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38342278)

  • 1. Human osteoclasts in vitro are dose dependently both inhibited and stimulated by cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC).
    Nielsen SSR; Pedersen JAZ; Sharma N; Wasehuus PK; Hansen MS; Møller AMJ; Borggaard XG; Rauch A; Frost M; Sondergaard TE; Søe K
    Bone; 2024 Apr; 181():117035. PubMed ID: 38342278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol.
    Pandelides Z; Aluru N; Thornton C; Watts HE; Willett KL
    Toxicol Sci; 2021 Jul; 182(1):44-59. PubMed ID: 33892503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
    Moore CF; Weerts EM
    Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
    Whyte LS; Ryberg E; Sims NA; Ridge SA; Mackie K; Greasley PJ; Ross RA; Rogers MJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16511-6. PubMed ID: 19805329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
    Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.
    Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
    Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
    Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites.
    Qian Y; Wang X; Markowitz JS
    Drug Metab Dispos; 2019 May; 47(5):465-472. PubMed ID: 30833288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
    Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
    Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and combined effects of cannabidiol and Δ
    Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
    J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botanically-Derived Δ
    Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.